Analysis of the structure of the local pharmaceutical market of calcium channel blockers

Arterial hypertension remains one of the most significant problems of modern medicine worldwide. According to WHO, 1.28 billion people suffer from arterial hypertension in the world, more than half of whom are not undergoing treatment. The disease causes enormous damage to the health of the population, being the strongest risk factor for morbidity and mortality from cardiovascular diseases. Scientists around the world have proven that taking antihypertensive drugs and maintaining blood pressure within normal limits increases life expectancy and reduces the risks of other cardiovascular pathologies.